{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:11:16Z","timestamp":1790629876428,"version":"4.1.0"},"reference-count":121,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004515","name":"Universiti Kebangsaan Malaysia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004515","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003093","name":"Malaysia Ministry of Higher Education","doi-asserted-by":"publisher","award":["FRGS\/1\/2019\/STG01\/UKM\/02\/3"],"award-info":[{"award-number":["FRGS\/1\/2019\/STG01\/UKM\/02\/3"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.bmcl.2024.129992","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T18:06:33Z","timestamp":1729274793000},"page":"129992","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Pyridine and Pyrimidine hybrids as privileged scaffolds in antimalarial drug discovery: A recent development"],"prefix":"10.1016","volume":"114","author":[{"given":"Lekkala","family":"Ravindar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siti Aishah","family":"Hasbullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.P.","family":"Rakesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saki","family":"Raheem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norzila","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lau Yee","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1235-4290","authenticated-orcid":false,"given":"Nurul Izzaty","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2024.129992_b0005","doi-asserted-by":"crossref","DOI":"10.1038\/s41564-019-0414-9","article-title":"Mosquito microevolution drives Plasmodium falciparum dynamics","volume":"4","author":"Gildenhard","year":"2019","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.bmcl.2024.129992_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112215","article-title":"Chalcone hybrids as privileged scaffolds in antimalarial drug discovery: A key review","volume":"193","author":"Qin","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0015","doi-asserted-by":"crossref","DOI":"10.1080\/17460441.2020.1740203","article-title":"Fluorinated scaffolds for antimalarial drug discovery","volume":"15","author":"Upadhyay","year":"2020","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.bmcl.2024.129992_b0020","unstructured":"World Health Organisation. World Malaria Report, 2020. Available online: https:\/\/www.who.int\/teams\/global-malariaprogramme\/reports\/world-malaria-report-2020."},{"key":"10.1016\/j.bmcl.2024.129992_b0025","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/med.21486","article-title":"Multistage inhibitors of the malaria parasite: emerging hope for chemoprotection and malaria eradication","volume":"38","author":"Poonam","year":"2018","journal-title":"Med Res Rev"},{"key":"10.1016\/j.bmcl.2024.129992_b0030","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.biopha.2018.05.009","article-title":"Drug targets for resistant malaria: Historic to future perspectives","volume":"104","author":"Kumar","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bmcl.2024.129992_b0035","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.3390\/molecules24193601","article-title":"Combination therapy strategies for the treatment of malaria","volume":"24","author":"Alven","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2024.129992_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111983","article-title":"Current progress in antimalarial pharmacotherapy and multi-target drug discovery","volume":"188","author":"Tibon","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0045","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1007\/s00044-020-02604-6","article-title":"A review of antimalarial activity of two or three nitrogen atoms containing heterocyclic compounds","volume":"29","author":"Chugh","year":"2020","journal-title":"Med Chem Res"},{"key":"10.1016\/j.bmcl.2024.129992_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115694","article-title":"Triazole hybrid compounds: A new frontier in malaria treatment","volume":"259","author":"Ravindar","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0055","article-title":"Pyrazole and pyrazoline derivatives as antimalarial agents: A key review","author":"Ravindar","year":"2022","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.bmcl.2024.129992_b0060","article-title":"Recent developments in antimalarial activities of 4-aminoquinoline derivatives","volume":"256","author":"Ravindar","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0065","article-title":"Exploring antimalarial potential: Conjugating organometallic moieties with organic fragments for enhanced efficacy","volume":"149","author":"Norazmi","year":"2024","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0070","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.3390\/ph14111174","article-title":"Synthesis, molecular docking, and antimalarial activity of hybrid 4-aminoquinoline-pyrano[2,3-c]pyrazole derivatives","volume":"14","author":"Shamsuddin","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bmcl.2024.129992_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116043","article-title":"Exploring diverse frontiers: Advancements of bioactive 4-aminoquinoline-based molecular hybrids in targeted therapeutics and beyond","volume":"264","author":"Ravindar","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0080","article-title":"Medicinal importance and chemosensing applications of pyridine derivatives: a review","author":"Abu-Taweel","year":"2022","journal-title":"Crit Rev Anal Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2022.103846","article-title":"Novel pyridine and pyrimidine derivatives as promising anticancer agents: A review","volume":"15","author":"Albratty","year":"2022","journal-title":"Arab J Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0090","doi-asserted-by":"crossref","first-page":"7187","DOI":"10.1080\/10406638.2021.1998144","article-title":"Pyrimidine-piperazine hybrids; recent synthesis and biological activities","volume":"42","author":"Al-Ghorbani","year":"2022","journal-title":"Polycycl. Aromat. Comp."},{"key":"10.1016\/j.bmcl.2024.129992_b0095","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00044-020-02656-8","article-title":"Pyrimidine and fused pyrimidine derivatives as promising protein kinase inhibitors for cancer treatment","volume":"30","author":"Abdellatif","year":"2021","journal-title":"Med Chem Res"},{"key":"10.1016\/j.bmcl.2024.129992_b0100","first-page":"272","article-title":"An overview on synthesis and biological activity of pyrimidines, N.a","volume":"15","author":"Mohamed","year":"2022","journal-title":"J. Adv Res. Rev."},{"key":"10.1016\/j.bmcl.2024.129992_b0105","first-page":"488","article-title":"A review on biological activity of pyrazole contain pyrimidine derivatives","volume":"11","author":"Mathew","year":"2022","journal-title":"World J Pharm Res"},{"key":"10.1016\/j.bmcl.2024.129992_b0110","first-page":"23","article-title":"Significance the biological activity to pyrimidine analogues","volume":"4","author":"March","year":"2020","journal-title":"Sci. J. Med. Res."},{"key":"10.1016\/j.bmcl.2024.129992_b0115","article-title":"Pyridine and pyrimidine derivatives as privileged scaffolds in biologically active agents","volume":"26","author":"Chiacchio","year":"2019","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0120","doi-asserted-by":"crossref","DOI":"10.2174\/1389557521666210126143558","article-title":"Antiviral activities of pyridine fused and pyridine containing heterocycles, a review (from 2000 to 2020)","volume":"21","author":"Alizadeh","year":"2021","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105374","article-title":"Pyridine and quinoline molecules as crucial protagonists in the never-stopping discovery of new agents against tuberculosis","volume":"151","author":"Villamizar-Mogotocoro","year":"2020","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.bmcl.2024.129992_b0130","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.2147\/DDDT.S329547","article-title":"The expanding role of pyridine and dihydropyridine scaffolds in drug design","volume":"15","author":"Ling","year":"2021","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.bmcl.2024.129992_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112915","article-title":"Small molecule therapeutics for tauopathy in Alzheimer\u2019s disease: walking on the path of most resistance","volume":"209","author":"Wang","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0140","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24224161","article-title":"Pyrido[2,3-d]pyrimidin-7(8H)-ones: synthesis and biomedical applications","volume":"24","author":"Jubete","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2024.129992_b0145","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.1c00138","article-title":"Discovery of the S1P2 antagonist GLPG2938 (1-[2-Ethoxy-6-(trifluoromethyl)-4-pyridyl]-3-[[5-methyl-6-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]pyridazin-3-yl]methyl]urea), a preclinical candidate for the treatment of idiopathic pulmonary fibrosis","volume":"64","author":"Mammoliti","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113499","article-title":"Design, synthesis and biological evaluations of a series of pyrido[1,2-a]pyrimidinone derivatives as novel selective FGFR inhibitors","volume":"220","author":"Ran","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115820","article-title":"Pyridine alkaloids with activity in the central nervous system","volume":"28","author":"Lin","year":"2020","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2008.02.007","article-title":"Design and synthesis of dual inhibitors of HIV reverse transcriptase and integrase: introducing a diketoacid functionality into delavirdine","volume":"16","author":"Wang","year":"2008","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0165","doi-asserted-by":"crossref","DOI":"10.2147\/TCRM.S159824","article-title":"Abiraterone acetate for early stage metastatic prostate cancer: patient selection and special considerations","volume":"14","author":"Castellan","year":"2018","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.bmcl.2024.129992_b0170","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2125.1992.tb04081.x","article-title":"In vitro activity of the enantiomers of mefloquine, halofantrine and enpiroline against Plasmodium falciparum","volume":"33","author":"Basco","year":"1992","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.bmcl.2024.129992_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/0002-9343(93)90390-B","article-title":"Efficacy of nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis","volume":"95","author":"Lister","year":"1993","journal-title":"Am J Med"},{"key":"10.1016\/j.bmcl.2024.129992_b0180","doi-asserted-by":"crossref","DOI":"10.12968\/denu.2016.43.2.186","article-title":"Antimuscarinics in older people: dry mouth and beyond","volume":"43","author":"Bostock","year":"2016","journal-title":"Dent Update"},{"key":"10.1016\/j.bmcl.2024.129992_b0185","article-title":"Clearance of the antihistamine doxylamine. Reduced in elderly men but not in elderly women","volume":"19","author":"Friedman","year":"1989","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.bmcl.2024.129992_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2006.06.002","article-title":"Inhibition of two different cholinesterases by tacrine","volume":"162","author":"Ahmed","year":"2006","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.bmcl.2024.129992_b0195","doi-asserted-by":"crossref","DOI":"10.1056\/NEJM198901123200201","article-title":"Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer","volume":"320","author":"Walan","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmcl.2024.129992_b0200","doi-asserted-by":"crossref","DOI":"10.1001\/jama.1984.03340340023018","article-title":"Thirty years after isoniazid. Its impact on tuberculosis in children and adolescents","volume":"251","author":"Hsu","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.bmcl.2024.129992_b0205","doi-asserted-by":"crossref","DOI":"10.1111\/j.1468-1331.2010.03089.x","article-title":"Myasthenia gravis requiring pyridostigmine treatment in a national population cohort","volume":"17","author":"Andersen","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.bmcl.2024.129992_b0210","article-title":"Effects of aminophylline, nikethamide, and sodium salicylate in respiratory failure","volume":"5117","author":"Westlake","year":"1959","journal-title":"BMJ"},{"key":"10.1016\/j.bmcl.2024.129992_b0215","doi-asserted-by":"crossref","DOI":"10.1042\/bj0960837","article-title":"Nicotinamide nucleotides in the erythrocytes of patients suffering from pellagra","volume":"96","author":"Raghuramulu","year":"1965","journal-title":"Biochem J"},{"key":"10.1016\/j.bmcl.2024.129992_b0220","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02605-20","article-title":"Enisamium reduces influenza virus shedding and improves patient recovery by inhibiting viral RNA polymerase activity","volume":"65","author":"Te Velthuis","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2024.129992_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2018.11.039","article-title":"Potent inhibitors of malarial P. falciparum protein kinase G: Improving the cell activity of a series of imidazopyridines","volume":"29","author":"Large","year":"2019","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2024.129992_b0230","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24224095","article-title":"The development of novel compounds against malaria: quinolines, triazolpyridines, pyrazolopyridines and pyrazolopyrimidines","volume":"24","author":"Pinheiro","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2024.129992_b0235","doi-asserted-by":"crossref","DOI":"10.1007\/s11030-024-10870-4","article-title":"Anticancer potential and structure activity studies of purine and pyrimidine derivatives: an updated review","author":"Manna","year":"2024","journal-title":"Mol Divers"},{"key":"10.1016\/j.bmcl.2024.129992_b0240","article-title":"A comprehensive review on pyrimidine analogs-versatile scaffold with medicinal and biological potential","volume":"1246","author":"Basha","year":"2021","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bmcl.2024.129992_b0245","article-title":"Biological and medicinal significance of pyrimidines: a review","volume":"9","author":"Patil","year":"2018","journal-title":"IJPSR Sci"},{"key":"10.1016\/j.bmcl.2024.129992_b0250","article-title":"One-pot and two-pot methods for chalcone derived pyrimidines synthesis and applications","volume":"56","author":"Farooq","year":"2021","journal-title":"J Heterocycl Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0255","article-title":"Multicomponent synthesis of purines and pyrimidines: from the origin of life to new sustainable approaches for drug-discovery applications","volume":"26","author":"Martina","year":"2023","journal-title":"Eur J Org Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.129833","article-title":"Synthesis and biological activity of pyrimidines-containing hybrids: Focusing on pharmacological application","volume":"1230","author":"Zarenezhad","year":"2021","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bmcl.2024.129992_b0265","doi-asserted-by":"crossref","first-page":"729","DOI":"10.30799\/jacs.239.21070203","article-title":"Use of pyrimidine and its derivative in pharmaceuticals: A review","volume":"7","author":"Nerkar","year":"2021","journal-title":"J. Adv. Chem. Sci."},{"key":"10.1016\/j.bmcl.2024.129992_b0270","doi-asserted-by":"crossref","first-page":"358","DOI":"10.22270\/jddt.v10i5.4295","article-title":"A review on pharmacological aspects of pyrimidine derivatives","volume":"10","author":"Verma","year":"2020","journal-title":"J. Drug Deliv. Ther."},{"key":"10.1016\/j.bmcl.2024.129992_b0275","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/cbdd.14026","article-title":"Chemistry and biological evaluation of pyrido[4,3-d]pyrimidines: A review","volume":"99","author":"Yadav","year":"2022","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.bmcl.2024.129992_b0280","first-page":"10","article-title":"Structure-activity relationships of pyrimidine derivatives and their biological activity-A review","volume":"19","author":"Natarajan","year":"2022","journal-title":"Med Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0285","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.bioorg.2018.02.027","article-title":"Synthesis and biological evaluation of pyrimidine bridged combretastatin derivatives as potential anticancer agents and mechanistic studies","volume":"78","author":"Kumar","year":"2018","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.cdc.2020.100363","article-title":"Anticancer activity of newly synthesized 1,2,4-oxadiazole linked 4-oxazolo[5,4-d]pyrimidine derivatives","volume":"27","author":"Perupogu","year":"2020","journal-title":"Chem Data Collect"},{"key":"10.1016\/j.bmcl.2024.129992_b0295","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1021\/acsmedchemlett.8b00086","article-title":"Azabicyclic fused pyrimidine derivatives useful for the treatment of Alzheimer\u2019s disease","volume":"9","author":"Blass","year":"2018","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmcl.2024.129992_b0300","doi-asserted-by":"crossref","first-page":"21","DOI":"10.53879\/id.58.05.12570","article-title":"Synthesis, in silico analysis and anticonvulsant activity of novel pyrimidine derivatives","volume":"58","author":"Aggarwal","year":"2021","journal-title":"Indian Drugs"},{"key":"10.1016\/j.bmcl.2024.129992_b0305","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.biocel.2018.10.007","article-title":"Enzymes of pyrimidine salvage pathways in intraerythrocytic Plasmodium falciparum","volume":"105","author":"Naguib","year":"2018","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.bmcl.2024.129992_b0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114597","article-title":"Design and synthesis of novel indole and indazole-piperazine pyrimidine derivatives with anti-inflammatory and neuroprotective activities for ischemic stroke treatment","volume":"241","author":"Wang","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111567","article-title":"Antihypertensive potential of selected pyrimidine derivatives: Explanation of underlying mechanistic pathways","volume":"139","author":"Irshad","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bmcl.2024.129992_b0320","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.3390\/molecules23112913","article-title":"Design, synthesis, molecular modeling, and biological evaluation of novel thiouracil derivatives as potential antithyroid agents","volume":"23","author":"Awad","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2024.129992_b0325","doi-asserted-by":"crossref","first-page":"934","DOI":"10.17344\/acsi.2020.5938","article-title":"Synthesis and evaluation on anticonvulsant and antidepressant activities of naphthoquinone derivatives containing pyrazole and pyrimidine fragments","volume":"67","author":"Polish","year":"2020","journal-title":"Acta Chim Slov"},{"key":"10.1016\/j.bmcl.2024.129992_b0330","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26082370","article-title":"Promising antidiabetic and antimicrobial agents based on fused pyrimidine derivatives: molecular modeling and biological evaluation with histopathological effect","volume":"26","author":"Bassyouni","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2024.129992_b0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104134","article-title":"New fused pyrimidine derivatives with anticancer activity: Synthesis, topoisomerase II inhibition, apoptotic inducing activity and molecular modeling study","volume":"103","author":"Nemr","year":"2020","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0340","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.3390\/molecules23123069","article-title":"Novel 5\u2032-norcarbocyclic pyrimidine derivatives as antibacterial agents","volume":"23","author":"Khandazhinskaya","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2024.129992_b0345","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1134\/S1070428022040200","article-title":"Green and catalyst-free synthesis of some new benzo[4,5]imidazo[1,2-a]pyrimidine derivatives as antimicrobial and antitubercular agents","volume":"58","author":"Panchani","year":"2022","journal-title":"Russ J Org Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0350","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s10593-010-0633-8","article-title":"Synthesis and antiviral evaluation of 1,3-dimethyl-6-(1H\u20131,2,3-triazol-1-YL)pyrimidine-2,4(1H,3H)-dione derivatives","volume":"46","author":"El-Etrawy","year":"2010","journal-title":"Chem Heterocycl Compd"},{"key":"10.1016\/j.bmcl.2024.129992_b0355","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/ddr.22058","article-title":"Design and synthesis of novel hexahydrobenzo[4,5]thieno[2,3-d]pyrimidine derivatives as potential anticancer agents with antiangiogenic activity via VEGFR-2 inhibition, and down-regulation of PI3K\/AKT\/mTOR signaling pathway","volume":"84","author":"Seif","year":"2023","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.bmcl.2024.129992_b0360","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/cbdd.13760","article-title":"Design, synthesis, and biological evaluation of piperidinyl-substituted [1,2,4]triazolo[1,5-a]pyrimidine derivatives as potential anti-HIV-1 agents with reduced cytotoxicity","volume":"97","author":"Huang","year":"2021","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.bmcl.2024.129992_b0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcab.2022.102539","article-title":"Structure-based design, drug-likeness, and pharmacokinetic studies of novel substituted pyrimidine derivatives as potent HCV NS3\/A4 protease inhibitors","volume":"46","author":"Ejeh","year":"2022","journal-title":"Biocatal Agric Biotechnol"},{"key":"10.1016\/j.bmcl.2024.129992_b0370","doi-asserted-by":"crossref","DOI":"10.1002\/slct.201801050","article-title":"Green synthesis, antimicrobial activity and cytotoxicity of novel fused pyrimidine derivatives possessing a trifluoromethyl moiety","volume":"3","author":"Al-Bogami","year":"2018","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bmcl.2024.129992_b0375","doi-asserted-by":"crossref","DOI":"10.1002\/slct.201903031","article-title":"Synthesis, in silico molecular docking, ADME evaluation and in vitro antiplasmodial activity of pyrimidine-based hybrid molecules","volume":"4","author":"Chopra","year":"2019","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bmcl.2024.129992_b0380","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/cbdd.14001","article-title":"Pyrimidine: An elite heterocyclic leitmotif in drug discovery-synthesis and biological activity","volume":"100","author":"Nadar","year":"2022","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.bmcl.2024.129992_b0385","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1039\/C6MD00084C","article-title":"Pyrimidine based antimalarials: Design strategies and antiplasmodial effects","volume":"7","author":"Singh","year":"2016","journal-title":"Med Chem Commun"},{"key":"10.1016\/j.bmcl.2024.129992_b0390","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/jccs.201900165","article-title":"Design of antimalarial agents based on pyrimidine derivatives as methionine aminopeptidase 1b inhibitor: Molecular docking, quantitative structure activity relationships, and molecular dynamics simulation studies","volume":"67","author":"Iman","year":"2020","journal-title":"J Chin Chem Soc"},{"key":"10.1016\/j.bmcl.2024.129992_b0395","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22137236","article-title":"Identification of 3,4-dihydro-2H,6H pyrimido[1,2-c][1,3]benzothiazin-6-imine derivatives as novel selective inhibitors of plasmodium falciparum dihydroorotate dehydrogenase","volume":"22","author":"Hartuti","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmcl.2024.129992_b0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114653","article-title":"New structural classes of antimalarials","volume":"242","author":"Rathod","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0405","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1039\/D0MD00244E","article-title":"Medicinal chemistry updates on quinoline- and endoperoxide-based hybrids with potent antimalarial activity","volume":"12","author":"Uddin","year":"2021","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.bmcl.2024.129992_b0410","first-page":"997","article-title":"Synthesis of pyrazolo[4,3:5,6]pyrano[2,3-d]pyrimidine derivatives and their antimicrobial, antimalarial and antituberculosis evaluation","volume":"57","author":"Vekariya","year":"2018","journal-title":"Indian J Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.102986","article-title":"Targeting malaria and Leishmaniasis: Synthesis and pharmacological evaluation of novel pyrazole-1,3,4-oxadiazole hybrids. Part II","volume":"89","author":"Verma","year":"2019","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0420","doi-asserted-by":"crossref","first-page":"11902","DOI":"10.1021\/acs.jmedchem.0c01152","article-title":"Synthesis and structure-activity relationship of dual-stage antimalarial pyrazolo[3,4-b]pyridines","volume":"63","author":"Eagon","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0425","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.bmc.2019.01.044","article-title":"New hybrid trifluoromethylquinolines as antiplasmodium agents","volume":"27","author":"da Silva","year":"2019","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0430","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1080\/10406638.2021.1909082","article-title":"Antitubercular, antimalarial activity and molecular docking study of new synthesized 7- chloroquinoline derivatives","volume":"42","author":"Patel","year":"2022","journal-title":"Polycycl Aromat Compd"},{"key":"10.1016\/j.bmcl.2024.129992_b0435","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.tetlet.2019.05.054","article-title":"Microwave-assisted, rapid synthesis of 2-vinylquinolines and evaluation of their antimalarial activity","volume":"60","author":"Huang","year":"2019","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.bmcl.2024.129992_b0440","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.3390\/biom10081197","article-title":"Plasmodium falciparum knockout for the GPCR-Like PfSR25 receptor displays greater susceptibility to 1,2,3-triazole compounds that block malaria parasite development","volume":"10","author":"dos Santos","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.bmcl.2024.129992_b0445","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ejmech.2017.12.051","article-title":"Antimalarial naphthoquinones. Synthesis via click chemistry, in vitro activity, docking to PfDHODH and SAR of lapachol-based compounds","volume":"145","author":"Brand\u00e3o","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0450","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00044-020-02642-0","article-title":"Synthesis, characterization and antimalarial activity of isoquinoline derivatives","volume":"30","author":"Theeramunkong","year":"2021","journal-title":"Med Chem Res"},{"key":"10.1016\/j.bmcl.2024.129992_b0455","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s11164-021-04607-3","article-title":"Anti-inflammation and antimalarial profile of 5-pyridine-2-yl-1H-[1,2,4]triazole-3\u2013carboxylic acid ethyl ester as a low molecular intermediate for hybrid drug synthesis","volume":"48","author":"Meva","year":"2022","journal-title":"Res Chem Intermed"},{"key":"10.1016\/j.bmcl.2024.129992_b0460","doi-asserted-by":"crossref","DOI":"10.1039\/D2NJ05302K","article-title":"Design and synthesis of novel glycyrrhetinic acid-triazole derivatives that exert anti-plasmodial activity inducing mitochondrial-dependent apoptosis in Plasmodium falciparum","volume":"47","author":"Kapkoti","year":"2023","journal-title":"New J Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0465","doi-asserted-by":"crossref","first-page":"9790","DOI":"10.1002\/slct.201801905","article-title":"Synthesis and antimalarial evaluation of [1, 2,3]-triazole-tethered sulfonamide-berberine hybrids","volume":"3","author":"Batra","year":"2018","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bmcl.2024.129992_b0470","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/jhet.3888","article-title":"Synthesis, characterization, and antiplasmodial efficacy of sulfonamide-appended [1,2,3]-triazoles","volume":"57","author":"Batra","year":"2020","journal-title":"J Heterocycl Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0475","doi-asserted-by":"crossref","unstructured":"Batra N, Rajendran V, Wadi I, Ghosh PC, Nath M, Synthesis and antimalarial activity of sulfonamide-attached coumarin-[1,2,3]-triazoles, Indian J Chem Sect B. 2020;59b:1545.","DOI":"10.56042\/ijcb.v59i10.35492"},{"key":"10.1016\/j.bmcl.2024.129992_b0480","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25194485","article-title":"A novel series of [1,2,4]triazolo[4,3-a]pyridine sulfonamides as potential antimalarial agents: in silico studies, synthesis and in vitro evaluation","volume":"25","author":"Karpina","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2024.129992_b0485","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.0c02022","article-title":"Novel antimalarial tetrazoles and amides active against the hemoglobin degradation pathway in Plasmodium falciparum","volume":"64","author":"Lawong","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2022.111905","article-title":"Rhenium(I) derivatives of aminoquinoline and imidazolopiperidine-based ligands: Synthesis, in vitro and in silico biological evaluation against Plasmodium falciparum","volume":"234","author":"Sovari","year":"2022","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.bmcl.2024.129992_b0495","doi-asserted-by":"crossref","DOI":"10.1039\/D0DT01935F","article-title":"Quinoline-triazole half-sandwich iridium(III) complexes: synthesis, antiplasmodial activity and preliminary transfer hydrogenation studies","volume":"49","author":"Melis","year":"2020","journal-title":"Dalton Trans"},{"key":"10.1016\/j.bmcl.2024.129992_b0500","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1002\/cbic.202000847","article-title":"Subcellular localisation of a quinoline-containing fluorescent cyclometallated IrIII complex in Plasmodium falciparum","volume":"22","author":"Melis","year":"2022","journal-title":"Chembiochem"},{"key":"10.1016\/j.bmcl.2024.129992_b0505","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.8b01972","article-title":"4-Aryl pyrrolidines as a novel class of orally efficacious antimalarial agents. Part 1: Evaluation of 4-aryl-N-benzylpyrrolidine-3-carboxamides","volume":"62","author":"Meyers","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0510","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/j.bmc.2019.03.061","article-title":"Synthesis and structure-activity relationships for new 6-fluoroquinoline derivatives with antiplasmodial activity","volume":"27","author":"Hochegger","year":"2019","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0515","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1039\/C8MD00608C","article-title":"Incorporation of an intramolecular hydrogen bonding motif in the side chain of antimalarial benzimidazoles","volume":"10","author":"Attram","year":"2019","journal-title":"Med Chem Commun"},{"key":"10.1016\/j.bmcl.2024.129992_b0520","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3897\/pharmacia.70.e107406","article-title":"Synthesis of chalcone derivatives with methoxybenzene and pyridine moieties as potential antimalarial agents","volume":"70","author":"Mulyana","year":"2023","journal-title":"Pharmacia"},{"key":"10.1016\/j.bmcl.2024.129992_b0525","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2174\/2213335607999200918155613","article-title":"Significance of microwave irradiation in synthesis of thiazolidin-4-one bearing pyrimidine analogues: Their in vitro antimicrobial, antituberculosis and antimalarial studies","volume":"7","author":"Patel","year":"2020","journal-title":"Curr. Microw. Chem."},{"key":"10.1016\/j.bmcl.2024.129992_b0530","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2174\/1570178617999201001153113","article-title":"1,2,4-triazoles clubbed pyrimidine compounds with synthesis, antimicrobial, antituberculosis, antimalarial, and anti-protozoal studies","volume":"118","author":"Patel","year":"2021","journal-title":"Lett Org Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0535","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2174\/1570178619666220111124104","article-title":"Microwave irradiated synthesis of pyrimidine containing, thiazolidin-4-ones: antimicrobial, anti-tuberculosis, antimalarial and anti-protozoa evaluation","volume":"19","author":"Soni","year":"2022","journal-title":"Lett Org Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0540","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1007\/s00044-018-2199-4","article-title":"Synthesis and anti-Plasmodium falciparum evaluation of novel pyrazolopyrimidine derivatives","volume":"27","author":"Silveira","year":"2018","journal-title":"Med Chem Res"},{"key":"10.1016\/j.bmcl.2024.129992_b0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112941","article-title":"Comparative study between the anti-P. falciparum activity of triazolopyrimidine, pyrazolopyrimidine and quinoline derivatives and the identification of new PfDHODH inhibitors","volume":"209","author":"Silveira","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0550","doi-asserted-by":"crossref","first-page":"12666","DOI":"10.1039\/C8NJ00670A","article-title":"Microwave assisted one-pot synthetic route to imidazo[1,2-: A] pyrimidine derivatives of imidazo\/triazole clubbed pyrazole and their pharmacological screening","volume":"42","author":"Prasad","year":"2018","journal-title":"New J Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0555","doi-asserted-by":"crossref","first-page":"e02347","DOI":"10.1128\/AAC.02347-17","article-title":"Synthesis, biological evaluation, and molecular modeling studies of chiral chloroquine analogues as antimalarial agents","volume":"62","author":"Kondaparla","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2024.129992_b0560","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1021\/acsmedchemlett.8b00496","article-title":"Hybridization of fluoro-amodiaquine (FAQ) with pyrimidines: Syn-thesis and antimalarial efficacy of FAQ-pyrimidines","volume":"10","author":"Tripathi","year":"2019","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmcl.2024.129992_b0565","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ejmech.2018.11.021","article-title":"N-Substituted aminoquinoline-pyrimidine hybrids: Synthesis, in vitro antimalarial activity evaluation and docking studies","volume":"162","author":"Maurya","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113330","article-title":"Design and synthesis of quinoline-pyrimidine inspired hybrids as potential plasmodial inhibitors","volume":"217","author":"Kayamba","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0575","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1021\/acsmedchemlett.2c00078","article-title":"Kumar, synthesis, anti-plasmodial activities, and mechanistic insights of 4-aminoquinoline-triazolopyrimidine hybrids","volume":"13","author":"Chowdhary","year":"2022","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmcl.2024.129992_b0580","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejmech.2018.02.021","article-title":"Pyrimidine-chloroquinoline hybrids: Synthesis and antiplasmodial activity","volume":"148","author":"Chopra","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0585","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1039\/D2MD00085G","article-title":"Thiamine analogues as inhibitors of pyruvate dehydrogenase and discovery of a thiamine analogue with non-thiamine related antiplasmodial activity","volume":"13","author":"Chan","year":"2022","journal-title":"RSC Med Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0590","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1007\/s11224-023-02142-y","article-title":"Design, synthesis, and in silico\u2013in vitro antimalarial evaluation of 1,2,3\u2013triazole\u2013linked dihydropyrimidinone quinoline hybrids","volume":"34","author":"Adigun","year":"2023","journal-title":"Struct Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0595","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202200545","article-title":"1,2,4-Triazole and benzimidazole fused dihydropyrimidine derivatives: Design, green synthesis, antibacterial, antitubercular, and antimalarial activities","volume":"356","author":"Mokariya","year":"2023","journal-title":"Arch Pharm"},{"key":"10.1016\/j.bmcl.2024.129992_b0600","article-title":"Synthesis, characterization, docking study and biological evaluation of new chalcone, pyrazoline, and pyrimidine derivatives as potent antimalarial compounds","volume":"14","author":"Alidmat","year":"2021","journal-title":"Arab J Chem"},{"key":"10.1016\/j.bmcl.2024.129992_b0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.115055","article-title":"Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents","volume":"248","author":"Pal","year":"2023","journal-title":"Eur J Med Chem"}],"container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X24003949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X24003949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T20:32:01Z","timestamp":1731529921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X24003949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":121,"alternative-id":["S0960894X24003949"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2024.129992","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pyridine and Pyrimidine hybrids as privileged scaffolds in antimalarial drug discovery: A recent development","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2024.129992","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"129992"}}